Actio Biosciences
$66.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Actio Biosciences is currently valued at $137.0M as of June 18, 2025. The company has raised a total of $121.0M in funding.
Capital Efficiency
With a capital efficiency ratio of 1.13x, Actio Biosciences has achieved a valuation that is 1.13 times the total capital raised. This metric indicates room for improvement in capital deployment.
Investment Perspective
Actio Biosciences's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Actio Biosciences Worth in 2025?
As of 2025, Actio Biosciences is valued at $137.0M, based on the company's Early Stage VC funding round in June 18, 2025. This valuation positions Actio Biosciences as one of the leading private companies in the sector.
Actio Biosciences Valuation History
Actio Biosciences's funding history demonstrates steady growth and investor confidence.
How Actio Biosciences Valuation is Determined
Private company valuations like Actio Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Actio Biosciences Valuation FAQs
Is Actio Biosciences profitable?
Actio Biosciences has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Actio Biosciences's valuation compare to competitors?
Actio Biosciences is valued at $137.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Actio Biosciences IPO?
Actio Biosciences has not announced plans for an initial public offering. Until an IPO, investors can access Actio Biosciences shares through secondary market platforms.